Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study.

Angel Paternina-Caicedo,David Santiago Quevedo,Diana Sofía Ríos,Diane Moyano,Nelson Alvis-Guzmán,Nelson Rafael Alviz-Zakzuk,Fernando Salcedo,Lina Moyano,Javier Ramírez-Suarez,Adrian D Smith,Fernando De la Hoz-Restrepo

Vaccine（2023）

引用 0|浏览5

暂无评分

摘要

Our study provides further evidence on the protective effect of mRNA vaccines for Omicron, and warrant that the duration of protection against symptomatic infection may last for only a few months.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要